Literature DB >> 19762241

Metastatic breast cancer patients: the forgotten heroes!

Fatima Cardoso.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19762241     DOI: 10.1016/j.breast.2009.09.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


× No keyword cloud information.
  5 in total

1.  Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinoma.

Authors:  Fresia Pareja; Melissa P Murray; Ryan Des Jean; Fumiko Konno; Maria Friedlander; Oscar Lin; Marcia Edelweiss
Journal:  J Am Soc Cytopathol       Date:  2017 Jan-Feb

2.  Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials.

Authors:  Zeina A Nahleh; Nancy U Lin; Antonio C Wolff; Fatima Cardoso
Journal:  Breast       Date:  2013-03-25       Impact factor: 4.380

Review 3.  National consensus in China on diagnosis and treatment of patients with advanced breast cancer.

Authors:  Binghe Xu; Xichun Hu; Zefei Jiang; Huiping Li; Jiayi Chen; Shude Cui; Qing Li; Ning Liao; Donggeng Liu; Jian Liu; Jinsong Lu; Kunwei Shen; Tao Sun; Yuee Teng; Zhongsheng Tong; Shulian Wang; Xiang Wang; Xiaojia Wang; Yongsheng Wang; Jiong Wu; Peng Yuan; Pin Zhang; Qingyuan Zhang; Hong Zheng; Da Pang; Guosheng Ren; Zhimin Shao; Zhenzhou Shen; Erwei Song; Santai Song
Journal:  Ann Transl Med       Date:  2015-10

4.  Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.

Authors:  Tari A King; Jaclyn P Lyman; Mithat Gonen; Amy Voci; Marina De Brot; Camilla Boafo; Amy Pratt Sing; E Shelley Hwang; Michael D Alvarado; Minetta C Liu; Judy C Boughey; Kandace P McGuire; Catherine H Van Poznak; Lisa K Jacobs; Ingrid M Meszoely; Helen Krontiras; Gildy V Babiera; Larry Norton; Monica Morrow; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

5.  ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Authors:  F Cardoso; A Costa; L Norton; E Senkus; M Aapro; F André; C H Barrios; J Bergh; L Biganzoli; K L Blackwell; M J Cardoso; T Cufer; N El Saghir; L Fallowfield; D Fenech; P Francis; K Gelmon; S H Giordano; J Gligorov; A Goldhirsch; N Harbeck; N Houssami; C Hudis; B Kaufman; I Krop; S Kyriakides; U N Lin; M Mayer; S D Merjaver; E B Nordström; O Pagani; A Partridge; F Penault-Llorca; M J Piccart; H Rugo; G Sledge; C Thomssen; L Van't Veer; D Vorobiof; C Vrieling; N West; B Xu; E Winer
Journal:  Ann Oncol       Date:  2014-09-18       Impact factor: 32.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.